With an expiration date still more than a year away, here's what the latest details reveal.
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a 20-fold rise in use of drugs to manage the condition among w ...
Taking ADHD medication might just save your life — and not in the way you’d expect. A groundbreaking study involving nearly 150,000 people reveals that those who take medication for their ADHD face ...
Please provide your email address to receive an email when new articles are posted on . Asian, Black and Hispanic children with ADHD were less likely to be prescribed medication early vs. white ...
From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.
UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...
“It’s like a manual radio. That white noise you would get when you’re in between stations and then finally the clarity when you tune in. My brain was entirely white noise, so many racing thoughts I ...
An analysis of U.S. Medicaid data found that 26.7% of autistic adults without intellectual disability had an ADHD diagnosis. This was the case for 40.2% of autistic adults with intellectual disability ...
ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results